Except for cholinesterase inhibitors, blockers of the NMDA receptor, antioxidants or blockers of oxidative deamination (including Gingko biloba), anti-inflammatory agents etc. can be a choose for treating Alzheimer’s disease [24]. This evidence concerns the gene BCHE and Alzheimer disease.